Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
MENQUADFI prescribed with off label diagnosis,Acquired absence of spleen with no reported adverse event; Initial information received on 01-Aug-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves a 52 years old male patient to whom Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] was prescribed with off label diagnosis,Acquired absence of spleen with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient was prescribed with an unknown dose of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine, Solution for injection (lot number, expiry date and strength not reported) via intramuscular route in unknown administration site for Acquired absence of spleen (Acquired asplenia) and prescribed with off label diagnosis with no reported adverse event (off label use). Action taken was not applicable. No follow up possible since reporter denied to respond to Sanofi PV Follow up.